This confidence granted by Banque des Territoires (Caisse des Depôts group) and Bright Pixel allows Sekoia.io to continue its expansion and to develop its international footprint. Sekoia.io, the European
European biotech AlgoTx, the developer of first-in-class treatment ATX01 for chemotherapy-induced peripheral neuropathy (CIPN), announced today the success of a €20M Series B fundraising led by Relyens